发明公开
EP1613330A1 COMBINATION OF A MACROLIDE T-CELL IMMUNOMODULATOR AND A CALCIFEROL FOR THE TREATMENT OF SKIN DISEASES OR OF INFLAMMATORY BOWEL DISEASE
审中-公开
大环内酯类T细胞免疫调节剂的WITH A骨化醇FOR皮肤疾病或炎症性肠疾病的治疗组合
- 专利标题： COMBINATION OF A MACROLIDE T-CELL IMMUNOMODULATOR AND A CALCIFEROL FOR THE TREATMENT OF SKIN DISEASES OR OF INFLAMMATORY BOWEL DISEASE
- 专利标题（中）： 大环内酯类T细胞免疫调节剂的WITH A骨化醇FOR皮肤疾病或炎症性肠疾病的治疗组合
-
申请号： EP04725344.8申请日： 2004-04-02
-
公开(公告)号： EP1613330A1公开(公告)日： 2006-01-11
- 发明人: GRASSBERGER, Maximilian , HIRSCH, Stefan , MAYER, Friedrich, Karl , MEINGASSNER, Josef, Gottfried , PAUL, Carle , SEKKAT, Nabila
- 申请人： Novartis AG , Novartis Pharma GmbH
- 申请人地址： Lichtstrasse 35 4002 Basel CH
- 专利权人： Novartis AG,Novartis Pharma GmbH
- 当前专利权人： Novartis AG,Novartis Pharma GmbH
- 当前专利权人地址： Lichtstrasse 35 4002 Basel CH
- 代理机构： Vallet, Lucien
- 优先权： GB0307865 20030404
- 国际公布： WO2004087170 20041014
- 主分类号： A61K31/593
- IPC分类号： A61K31/593 ; A61K31/453 ; A61P17/00 ; A61P1/00
摘要：
Synergistic combinations of a macrolide T-cell immunomodulator or immunosuppressant such as 33-epichloro-33-desoxyascomycin and a calciferol such as calcipotriol or tacalcitol are provided, which are useful in particular in the treatment of dermatological diseases such as atopic dermatitis, acne and psoriasis, or of inflammatory bowel disease (IBD).
信息查询
